At present, bovine mastitis is one of the most costly diseases affecting animal health and welfare. Escherichia coli (E. coli) is considered to be one of the main pathogens causing mastitis with clinical signs in dairy cattle. However, the cure rate of E. coli mastitis is low, and the pathogenesis of E. coli mastitis is not completely known. In order to develop new strategies for the rapid detection of E. coli mastitis, a comprehensive molecular investigation of E. coli mastitis is necessary. Hence, this study integrated three microarray data sets to identify the potential key candidate genes in dairy cow in response to E. coli mastitis. Differentially expressed genes (DEGs) were screened in mammary gland tissues with live E. coli infection. Furthermore, the pathways enrichment of DEGs were analyzed, and the protein-protein interaction (PPI) network was performed. In total, 105 shared DEGs were identified from the three data sets. The DEGs were significantly enriched in biological processes mainly involved in immunity. The PPI network of DEGs was constructed with 102 nodes and 546 edges. The module with the highest score through MCODE analysis was filtered from PPI; 18 central node genes were identified. However, in addition to immunerelated pathways, some of the 18 DEGs were involved in signaling pathways triggered by other diseases. Considering the specificity of biomarkers for rapid detection, IL8RB, CXCL6, and MMP9 were identified as the most potential biomarker for E. coli mastitis. In conclusion, the novel DEGs and pathways identified in this study can help to improve the diagnosis and treatment strategies for E. coli mastitis in cattle.
INTRODUCTION
Domesticated cattle not only provide a significant source of nutrition but also provide a livelihood for nearly 6.6 billion humans (Elsik et al., 2009) . Bacterial infection is one of the most important enemies of the cattle farming industry, causing significant losses. For example, bovine mastitis caused mostly by bacterial infection, resulting in losses of up to $2 billion per year in the United States alone. Aside from the economic losses, mastitis can impair animal welfare, and poses a threat to human health since it may be responsible for transfer of antimicrobial resistance and for food poisoning (Johler et al., 2015; Käppeli et al., 2019) . Escherichia coli (E. coli) which as a prevalent environmental pathogen that routinely colonizes dairy cattle is one of the main pathogens causing mastitis (Buitenhuis et al., 2011) . E. coli often leads to severe clinical mastitis and induces a distinct acute phase response (APR) (Petzl et al., 2018) .
To date, the conventional method of treatment for E. coli mastitis is the use of antibiotics. However, the treatment using antibiotics is often less than 50% effective and leads to premature culling in many cases (Schmelcher et al., 2015) . Alternative options are urgently needed for E. coli mastitis treatment. A deeper understanding of the molecular basis of E. coli mastitis may uncover new ways in battling this costly disease. Moreover, the comprehensive molecular investigation of E. coli mastitis may aid in the identification of new biomarkers for the rapid detection, and personalized therapy.
Microarray is a gene detection technique; using microarray can quickly detect the gene expression information in animals under infectious disease, which is particularly suitable for differentially expressed gene (DEG) screening. With the widespread use of microarray technology, a large amount of raw data about gene expression has been generated, and most of the data have been stored in public databases. The integration and reanalysis of these raw data can provide valuable information for new researches (Guo et al., 2017) . In recent years, many microarray data analysis studies on E. coli mastitis have been carried out, and hundreds of DEGs have been identified (Han, 2019) . For instance, a study identified 928 DEGs involved in the mammary gland with E. coli mastitis (Buitenhuis et al., 2011) . Another study found 2,154 DEGs in E. coli mastitis vs. control treatment (Mitterhuemer et al., 2010) . The results of different independent studies are always limited by the samples with environment, breed, population, and specific animal differences. Therefore, it is difficult to use differential genes obtained in a single independent study as biomarkers of E. coli mastitis. So far, the performance of the most mastitis detection systems do not meet the high accuracy required for clinical diagnosis needs of mastitis in cattle (Jensen et al., 2016) . The aim of developmental research is to enhance the diagnostic efficiency of bovine mastitis with including several biomarkers on one test strip. The integrated bioinformatics methods combining with microarray technique will be innovative and might promote the appearance of test strip containing several biomarkers.
There are many gene expression profiles of E. coli-treated samples in the NCBI-Gene Expression Omnibus (NCBI-GEO) database. Most of these studies use primary mammary epithelial cells as test subjects to obtain data, and a small part of them were in vivo experiments using cows. However, primary mammary epithelial cells experiments are of limited significance because the in vitro cell testing does not mimic the complex environment with interactions between pathogens, antimicrobials, and components of the host's immune response inside the mammary gland. Therefore, we integrated microarray data sets obtained from in vivo experiments with live E. coli infection to identify key candidate genes and pathways in E. coli mastitis of cows. It is anticipated that these results may provide more accurate, practically reliable biomarkers for early diagnosis and individualized prevention and therapy of bovine E. coli mastitis.
MATERIALS AND METHODS

Data Set Collection and Identification of DEGs
The transcription profile data sets of bovine mammary gland with or without live E. coli infection were downloaded from NCBI-GEO database (https://www.ncbi.nlm.nih.gov/gds/). The accession number was GSE15020, GSE24217, and GSE50685. These studies used the "Affymetrix Bovine Genome Array" platform GPL2112, which contains 24,128 genes. A total of 22 E. coli mastitis cases and 19 normal mammary gland data were obtained ( Table 1) . The raw data (.CEL files) of these three microarray data sets were downloaded. R software (Version 3.5.1; https://www.r-project.org/), affy package (https://bioconductor.org/packages/release/bioc/html/ affy.html), and affyPLM (http://bioconductor.org/packages/ release/bioc/html/affyPLM.html) package were used for raw data analysis (Li et al., 2019) . The raw data in CEL format were converted into expression measures. Log scale robust multiarray analysis (RMA) background correction, quantile normalization, pmonly (perfect match correction), and median polish were performed in the R software (Li et al., 2019) . RMA functions are provided by affy package (Irizarry et al., 2003) . After these processes, we got the gene expression matrix. Eventually, the Linear Models for Microarray Data (LIMMA; http://www.bioconductor.org/packages/release/bioc/html/ limma.html) package from Bioconductor was applied to identify DEGs by comparing expression value in mammary gland with or without E. coli infection. DEGs were identified with classical t test. A |log 2 fold change (FC)| > 1 and P value < 0.05 were regarded as the cutoff criterion for DEGs.
Enrichment Analyses of DEGs
In this study, notably relevant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) analyses were carried out using the DAVID (Database for Annotation, Visualization and Integrated Discovery) Bioinformatics Resources 6.8 (https://david.ncifcrf.gov/). P < 0.01 was chosen as the cutoff criteria. R software was used for data visualization.
Identification of Key Candidate Genes With Protein-Protein Interaction (PPI) Network Analysis and Module Mining
The STRING database (Version 11.0; https://string-db.org/) was used to annotate functional interactions between DEGs and other genes. Based on this information, PPI network was visualized by Cytoscape (Version 3.7.1) (Smoot et al., 2010) . Then Cytoscape plugin: MCODE and CentiScape were used to search modules of highly inter-connected nodes from the PPI network complex. Moreover, the function and pathway enrichment analysis of DEGs in the modules were performed by using DAVID.
RESULTS
Identification of DEGs
To identify DEGs in E. coli mastitis, three original microarray data sets were downloaded from NCBI-GEO database. Using the calculating criteria of P < 0.05 and absolute log 2 FC > 1, we extracted 663, 181, and 192 DEGs from the expression profile data sets GSE15020, GSE24217, and GSE50685, respectively. Employing R software and ggplot2 package, we developed Volcano Plot of the DEGs for the three expression profile data sets ( Figure S1 ). The genes identified are in the same direction from each study. Next, we integrated the three groups of DEGs and performed bioinformatics analysis. The results are shown in Figure 1 . A total of 105 DGEs were identified from the three profile data sets, including 98 up-regulated genes, 6 downregulated genes, and 1 aberrantly expressed gene SLC2A3 in the E. coli treatment samples compared to healthy samples ( Table 2) .
Functional and Pathway Enrichment Analysis
To acquire further understanding of the functions of identified DEGs, all DEGs were uploaded to DAVID. GO biological process (BP) terms and KEGG pathways were enriched for 105 candidate DEGs in E. coli mastitis. The top 20 BP terms according to P value are shown in Figure 2 . The data showed that DEGs were mainly involved in GO terms about immunity such as inflammatory response, immune response, innate immune response. DEGs mainly enriched in extracellular space, extracellular exosome, extracellular region, and external side of plasma membrane in the molecular function term. In these candidate DEGs of E. coli mastitis, 27 KEGG pathways were found to be enriched with P < 0.05 as the cutoff point, such as the TNF signaling pathway, chemokine signaling pathway, and cytokine-cytokine receptor interaction ( Figure 3 ).
Identification of Key Candidate Genes With PPI Network Analysis and Modular Analysis
The PPI network of DEGs was constructed in the STRING database which has 102 nodes and 546 edges. A total of 102 DEGs (except BASP1, BNBD-9-LIKE, and GPX1) were filtered into the DEGs PPI network complex. The PPI network was visualized by using Cytoscape software (Figure 4) . Based on the STRING database, the DEGs with the highest PPI scores identified by the Cytoscape plugin: MCODE and CentiScape with three centrality methods were shown in Table 3 . Among the 102 nodes, 37 central node genes were identified with the filtering of node degree >10. The most significant 10 node degree genes were shaped as diamond with yellow in Figure 4 . The module with the highest score through MCODE analysis was filtered from PPI. This module consisted of 18 nodes and 144 edges ( Figure 5) , which are mainly associated with inflammatory response, immune response, TNF signaling pathway, and rheumatoid arthritis, etc. (Tables 4 and 5). All the 18 genes belong to high PPI score genes ( Table 3) . The log 2 FC of these genes in three microarray data sets were summarized, and the top 10 genes with high log 2 FC were listed in Table 6 . These genes are significantly up-regulated in E. coli mastitis tissues. These genes are key genes associated with E. coli mastitis.
DISCUSSION
Despite the research on mastitis having lasted for a long time, the detrimental economic losses caused by mastitis remains unchanged (Petzl et al., 2018) . Early diagnosis is very important due to the high costs of mastitis. However, most current detection systems do not meet the high accuracy required for clinical diagnosis needs of mastitis (Jensen et al., 2016) . Nowadays, somatic cell count (SCC) and California mastitis test (CMT) are often used in the diagnosis of mastitis.
FIGURE 1 | The DEGs between (E. coli) mastitis and normal tissues in three original microarray data sets (GSE15020, GSE24217, and GSE50685) were identified.
Mastitis can cause significant milk changes such as the presence of clots in milk, milk discoloration, and high levels of leukocyte numbers which lead to a rise in SCC. Therefore, SCC has been used as the gold standard for decades to diagnose subclinical mastitis. As SCC requires submission of sample to a laboratory for automated cell counting, it's very time-consuming. In addition, SCCs do not always correlate with mastitis, and they may be affected by other factors (e.g., lactation number, stage of lactation, milk production level, stress, season, and breed) (Duarte et al., 2015) . CMT is based on the principle of the addition of a detergent to a milk sample with a high cell count which promotes cell lysis, nucleic acid release, and formation of a "gel-like" matrix. The CMT is quick, cheap, and simple, but the interpretation can be subjective, and this might result in false positives and negatives (Viguier et al., 2009) . Therefore, it is urgent to develop a new diagnosis system which could be adapted to rapid, on-farm diagnostic systems. Development of new biomarkers for diagnosis of mastitis has been considered as the trend of mastitis detection (Duarte et al., 2015) . A biomarker is a characteristic that can be measured and evaluated as an indicator of pathological processes, or pharmacological responses to therapeutic interventions. Genes coding for proteins such as haptoglobin, cathelicidin antimicrobial peptide, and lingual antimicrobial peptide have been identified as potential biomarkers for mastitis detection (Sharifi et al., 2018) . At present, antibiotics are mainly used as systemic treatment of mastitis (Porter et al., 2016) . Antibiotic should be chosen based on specific mastitis pathogen. Therefore, the exploration of biomarkers for a specific pathogen is also conducive to the selection of appropriate antibiotic therapy. Combined with previous studies on biomarkers, the genes detected in this experiment have the potential to develop test strips which include several biomarkers on one test strip, and this can enhance the diagnostic efficiency.
Here, we performed bioinformatical analysis on three microarray profile data sets to identify key genes that may be significantly involved in response to bovine E. coli mastitis. To obtain unique genes and pathways associated with E. coli mastitis, for the first time, we only selected original microarray data sets obtained from in vivo experiments with live E. coli TABLE 2 | One hundred and five DEGs were identified from the three profile data sets, including 98 up-regulated genes, 6 down-regulated genes, and 1 aberrantly expressed gene SLC2A3 in the E. coli treatment samples, compared to healthy samples.
DEGs
Gene Name VCAM1, VASP, UGDH, TXN, TUBB, TREM1, TNFRSF1A, TNFAIP6, TLR2, TIMP1, SOCS3, SLC1A1, SLC11A1, SERPINE2, SERPINE1, SERPINA3,  SELL, SCIN, SAA3, S100A4, S100A12, RETN, RAC2, QKI, EIF2AK2, PRDX5, PLAUR, PLAU, PLA2G7, PCTP, NTS, NT5C2, NFKBIA, NCF2, NCF1,  MX1, MT1A, MMP9, LOC407171, LGALS1, LAP, ITGB6, ITGB2, ITGA2, ISG15, IL8RB, CXCL8, IL6, IL2RA, IL1RN, IL1B, IL1A, IL18, IFNAR2,  IFITM3, ICAM3, ICAM1 , GNAI2, GNAI1, GAPDH, F5, ETS2, DNASE2, DGAT2, DEFB1, CYBA, CXCL6, CXCL2, GRO1, CTSZ, CTSS, CTSC, VCAN, CORO1A, CHI3L1, CD97, CD69, CD44, CCL3, CCL20, CCL2, CASP4, CAPG, CA2, BPIFB1, TSPO, DEFB5, PYCARD, ARRB1, ARG2, ARF2, ANXA1, ADAMTS4, ADA, ACADVL, BNBD-9-LIKE, BASP1, GPX1 Down-regulated SPADH1, SLC38A3, MUC15, CNGA1, ACSM1, ALOX15
Up-regulated
infection. The results confirmed the most important findings in previous individual studies such as induction of the responses related to immune response, inflammation, and TNF signaling pathway (Buitenhuis et al., 2011; Günther et al., 2011) . In the current research, the top-ranked genes were CXCL8, CXCL2, IL8RB, CXCL6, GRO1, IL6, IL1B, MMP9, ICAM1, and TLR2 ( Table 6 ). This result similar to previous studies such as Sharifi et al. (2018) , who found CXCL8, CXCL2, and GRO1 were the top three genes associated with E. coli mastitis, and Han (2019) found CXCL2 and GRO1 were key genes in both the E. coli and the Staphylococcus aureus mastitis. The consistency of these key genes proves the validity of our study. Importantly, new key genes and pathways associated with E. coli mastitis were obtained by this bioinformatical analysis. IL8RB and CXCL6 are key genes newly identified through our analysis. More importantly, for the first time, this study found that the DEGs associated with E. coli mastitis were involved in signaling pathways triggered by other diseases ( Table 5) . For example, CXCL8, CXCL2, or GRO1 were involved in rheumatoid arthritis, legionellosis, salmonella infection, and so on. The new finding may contribute to understanding the molecular basis of mastitis pathogenesis. However, this also indicates that those genes may not be suitable as a molecular biomarker of E. coli mastitis on account of biomarker should be specific for a disease and should remain unchanged by unrelated disorders. Therefore, after removing genes that cross with other diseases, only IL8RB, CXCL6, and MMP9 have the potential to be biomarker of E. coli mastitis in this study.
Interleukin 8 (IL8) is an important chemokine and plays a major role in the recruitment of neutrophils and lymphocytes from peripheral sites to the mammary gland during E. coli mastitis. IL8 has been confirmed to be produced by epithelial cells in the mammary gland respond to E. coli infection (Boehmer et al., 2008) . However, these effects of IL8 must be achieved by binding to the corresponding receptors; during this process, IL8RB is the receptor gene of IL8. Moreover, IL8RB has exhibited an important role in immune function during mastitis infection, and it belongs to the promising candidate genes contributing in bovine mastitis (El Nahas et al., 2017) . Consistent with the above research, in this study, IL8RB was identified as a key gene in response to E. coli mastitis. Therefore, its role during E. coli mastitis should be further studied.
Chemokines are a family of proteins with diverse functions that mediate a variety of inflammatory reactions (Gray et al., 2005) . Chemokine ligand 6 (CXCL6) is mainly secreted by macrophages, epithelial cells, and stromal cells and has chemotactic granulocytes and antimicrobial and immune functions. CXCL6 is also known as granulocyte chemotactic protein 2 (GCP-2). There was evidence that indicated the upregulation of CXCL6 gene expression in bovine mammary epithelial cell line with bacterial infection (Yu et al., 2010) and in infected gland (Rinaldi et al., 2010) . Combined with the analysis of this study, it shows again that CXCL6 plays an important role in cow responses to E. coli mastitis. Matrix metalloproteinases (MMPs) are a family of calciumdependent zinc-containing endopeptidases which are synthesized and secreted by various cells, such as neutrophils and macrophages, and play important roles in inflammation (Vandooren et al., 2013) such as bovine mammary epithelial cell with E. coli mastitis (Zhao and Lacasse 2008) . This family of proteases have five subfamilies, of which MMP9 is one of the most studied. It has been shown that the levels of expression of MMP9 in cases of bovine E. coli mastitis (Caggiano et al., 2019) and in goat mammary gland epithelial cells with S. aureus infection (Li et al., 2016) were increased. Considering all the results, MMP9 may be a good candidate for biomarker of E. coli mastitis diagnosis.
In view of the fact that the performances of the most current bovine mastitis detection systems do not meet the high accuracy required for clinical diagnosis needs of mastitis (Jensen et al., 2016) , the main purpose of this study is to identify potential genes that can be used as biomarkers for the diagnosis of E. coli mastitis. Although these genes have been identified in this study and had been preliminarily confirmed in previous animal or cell 
Term
Description P-value Genes GO:0006954 Inflammatory response 6.48E−11 CCL3, CCL2, CCL20, IL18, CXCL2, TLR2, CXCL8, GRO1 GO:0006955
Immune response 6.48E−11 CCL3, CCL2, IL18, CXCL2, IL1B, CXCL8, GRO1, IL1A GO:0070098
Chemokine-mediated signaling pathway 1.55E−09 CCL3, CCL2, CCL20, CXCL2, CXCL8 GO:0071347
Cellular response to interleukin-1 2.70E−07 CCL3, IL6, CCL2, CCL20, CXCL8 GO:0060326
Cell chemotaxis 2.70E−07 CCL2, CCL20, CXCL2, GRO1 GO:0071356
Cellular response to tumor necrosis factor 6.37E−07 CCL3, IL6, CCL2, CCL20, CXCL8 GO:0031663
Lipopolysaccharide-mediated signaling pathway 4.97E−06 CCL3, CCL2, IL18, NFKBIA GO:0071346
Cellular response to interferon-gamma 1.08E−05 CCL3, CCL2, CCL20, GAPDH GO:0030593
Neutrophil chemotaxis 2.42E−05 CCL3, CCL2, CCL20, CXCL8 GO:0032496
Response to lipopolysaccharide 1.34E−04 CXCL2, NFKBIA, CXCL8 Cytokine-cytokine receptor interaction 8.26E−09 CCL3, IL6, CCL2, CCL20, IL18, IL1B, CXCL8, IL1A bta04621
NOD-like receptor signaling pathway 6.70E−08 IL6, CCL2, IL18, IL1B, NFKBIA, CXCL8 bta04620
Toll-like receptor signaling pathway 6.85E−08 CCL3, IL6, TLR2, IL1B, NFKBIA, CXCL8 bta04062
Chemokine signaling pathway 7.49E−08 CCL3, CCL2, CCL20, CXCL2, NFKBIA, CXCL8, GRO1 experiments, these genes still need more laboratory-based studies and farm practice to confirm.
CONCLUSIONS
A total of 105 DEGs related to mastitis were identified from microarray data sets of in vivo experiments with live E. coli infection. After further integrated bioinformatical analysis, IL8RB, CXCL6, and MMP9 were identified as the most potential biomarker for E. coli mastitis. In conclusion, this study provided an extensive bioinformatics analysis of DEGs and revealed a series of targets and pathway for further study to battle with E. coli mastitis.
